Publication
New barriers to pharma deals: FTC challenges Amgen / Horizon merger without alleging product overlaps
The US FTC filed a lawsuit to block Amgen Inc.’s US$27.8 million acquisition of Horizon Therapeutics PLC.
Publication
The US FTC filed a lawsuit to block Amgen Inc.’s US$27.8 million acquisition of Horizon Therapeutics PLC.
Publication
The US FTC filed a lawsuit to block Amgen Inc.’s US$27.8 million acquisition of Horizon Therapeutics PLC.
Publication
Norton Rose Fulbright lawyers Roger Kuan, Jason Novak, Apurv Gaurav, Nathanael Green, Bernard O'Shea, Rohan Sridhar, Bri...
Publication
The US FTC filed a lawsuit to block Amgen Inc.’s US$27.8 million acquisition of Horizon Therapeutics PLC.
© Norton Rose Fulbright LLP 2023